Victoria A. Federico, Hannah A. Richards, Julie A. Talbert, Jocelyn R. Leal, Jennifer A. Gaddy, Steven D. Townsend, David E. Cliffel
{"title":"Electrochemical Cytokine Profiling Reveals Dual Immunomodulatory Effects of Human Milk Oligosaccharides in THP-1 Macrophages","authors":"Victoria A. Federico, Hannah A. Richards, Julie A. Talbert, Jocelyn R. Leal, Jennifer A. Gaddy, Steven D. Townsend, David E. Cliffel","doi":"10.1021/acsinfecdis.6c00388","DOIUrl":null,"url":null,"abstract":"<p>Human milk oligosaccharides\r\n(HMOs) are bioactive carbohydrates\r\nthat govern host–microbe interactions and immune regulation.\r\nBeyond their antimicrobial and antibiofilm functions, HMOs have been\r\nshown to modulate inflammatory pathways by altering cytokine expression,\r\nincluding interleukin-1β (IL-1β) and tumor necrosis factor-α\r\n(TNF-α), which are key mediators in infection and inflammation\r\nassociated complications. In this study, we characterize the effects\r\nof HMOs on cytokine secretion in THP-1 macrophages stimulated with <em>lipopolysaccharides</em> using a validated magnetic bead\r\nelectrochemical sandwich assay (MBESA). The electrochemical assay\r\nenabled precise quantification of cytokine responses and revealed\r\nthat HMO treatment attenuated proinflammatory signaling in LPS stimulated\r\nmacrophages. These findings provide new insights into the immunomodulatory\r\nproperties of HMOs and demonstrate the utility of electrochemical\r\nbiosensing platforms for rapid, sensitive assessment of cellular inflammatory\r\nresponses. Future studies will expand this approach to microphysiological\r\nsystems to further elucidate HMO mediated regulation of immune signaling.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 10","pages":"3398–3407"},"PeriodicalIF":4.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00388","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Human milk oligosaccharides
(HMOs) are bioactive carbohydrates
that govern host–microbe interactions and immune regulation.
Beyond their antimicrobial and antibiofilm functions, HMOs have been
shown to modulate inflammatory pathways by altering cytokine expression,
including interleukin-1β (IL-1β) and tumor necrosis factor-α
(TNF-α), which are key mediators in infection and inflammation
associated complications. In this study, we characterize the effects
of HMOs on cytokine secretion in THP-1 macrophages stimulated with lipopolysaccharides using a validated magnetic bead
electrochemical sandwich assay (MBESA). The electrochemical assay
enabled precise quantification of cytokine responses and revealed
that HMO treatment attenuated proinflammatory signaling in LPS stimulated
macrophages. These findings provide new insights into the immunomodulatory
properties of HMOs and demonstrate the utility of electrochemical
biosensing platforms for rapid, sensitive assessment of cellular inflammatory
responses. Future studies will expand this approach to microphysiological
systems to further elucidate HMO mediated regulation of immune signaling.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.